Corcept Therapeutics
CORT
CORT
201 hedge funds and large institutions have $1.59B invested in Corcept Therapeutics in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 78 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $1.77B → $1.59B (-$177M)
21% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 78
38% less call options, than puts
Call options by funds: $4.2M | Put options by funds: $6.78M
Holders
201
Holding in Top 10
2
Calls
$4.2M
Puts
$6.78M
Top Buyers
| 1 | +$16.8M | |
| 2 | +$6.13M | |
| 3 | +$3.96M | |
| 4 |
Goldman Sachs
New York
|
+$3.26M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$3.1M |
Top Sellers
| 1 | -$23.9M | |
| 2 | -$5.4M | |
| 3 | -$4.69M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$3.79M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$3.43M |